Related Experiment Video
Updated: Aug 8, 2026
07:42
An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
The changing epidemiology of invasive fungal infections: new threats
1Department of Hematology and Oncology, Klinikum Ernst von Bergmann, Potsdam, Germany. gmaschmeyer@klinikumevb.de
International Journal of Antimicrobial Agents
|May 19, 2006
Abstract:
The epidemiology of invasive fungal infections is currently at a crucial stage. Potentially fatal fungal strains are emerging that are resistant to many commonly used antifungal agents. It is therefore important to recognize and minimize the major risk factors associated with infection. This paper summarizes the key epidemiological data.
Insights
Emerging drug-resistant fungal strains pose a significant threat. Recognizing and minimizing infection risk factors is crucial for managing invasive fungal infections.
Area of Science:
- Mycology
- Epidemiology
- Infectious Diseases
Background:
- Invasive fungal infections (IFIs) are a growing global health concern.
- Emergence of antifungal resistance in pathogenic fungi complicates treatment.
- Identification of key risk factors is essential for effective prevention strategies.
Purpose of the Study:
- To summarize current epidemiological data on invasive fungal infections.
- To highlight the increasing challenge of antifungal resistance.
- To underscore the importance of risk factor identification and mitigation.
Main Methods:
- Review of existing epidemiological studies and surveillance data.
- Analysis of trends in fungal pathogen prevalence and antifungal susceptibility.
- Synthesis of information on risk factors associated with IFIs.
Main Results:
- Significant increase in the incidence of IFIs globally.
- Detection of emerging fungal strains with resistance to multiple antifungal drugs.
- Identification of patient populations and clinical settings with high IFI risk.
Conclusions:
- The epidemiology of IFIs is evolving, necessitating urgent attention.
- Antifungal stewardship and infection control are critical.
- Further research into novel antifungal therapies and prevention methods is required.
More Related Videos
Related Concept Videos
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:26Factors Affecting the Risk of Infection
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
01:28Fungal Phylum Microsporidia
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
01:28Infectious Diseases and Their Occurrence
Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...